Transplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsBone Marrow TransplantationCytomegalovirus InfectionsRoseolovirus InfectionsHistocompatibility TestingAspergillosisTreatment OutcomeStem CellsTransplantation ChimeraTissue DonorsAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationCytomegalovirusGraft SurvivalRetrospective StudiesRecurrenceGraft vs Tumor EffectBusulfanHematopoietic Stem CellsGraft vs Leukemia EffectImmunosuppressive AgentsMyeloablative AgonistsRemission InductionVidarabineCombined Modality TherapyKidney TransplantationSurvival AnalysisLeukemiaMultiple MyelomaHematopoietic Stem Cell MobilizationHistocompatibilityTransplantationLiver TransplantationLeukemia, Myeloid, AcuteSurvival RateWhole-Body IrradiationSalvage TherapyTime FactorsGraft RejectionDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCyclophosphamideTransplantation ImmunologyAcute DiseaseTransplantation, IsogeneicImmunocompromised HostAntineoplastic AgentsT-LymphocytesCord Blood Stem Cell TransplantationLymphocyte TransfusionSiblingsMelphalanMyelodysplastic SyndromesGranulocyte Colony-Stimulating FactorAntigens, CD34ImmunosuppressionHepatic Veno-Occlusive DiseaseHeart TransplantationFollow-Up StudiesNeoplasm, ResidualPrognosisCyclosporineOpportunistic InfectionsEmbryonic Stem CellsHLA AntigensLeukemia, MyeloidVirus ActivationMycosesLung TransplantationAdult Stem CellsAnemia, AplasticLymphoma, Non-HodgkinHematologic DiseasesChemotherapy, AdjuvantHodgkin DiseaseChimerismAntilymphocyte SerumProspective StudiesBone Marrow CellsMinor Histocompatibility AntigensRisk FactorsAntibodies, NeoplasmCell TransplantationNuclear FamilyFatal OutcomeOrgan TransplantationMesenchymal Stem Cell TransplantationBlood Component RemovalGanciclovirLymphomaAntibodies, MonoclonalLeukocyte Transfusion